Skip to content

The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study

The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06397976
Enrollment
37
Registered
2024-05-03
Start date
2024-04-17
Completion date
2024-11-05
Last updated
2025-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eyes With Abnormal Anterior Segment, Eyes With Normal Anterior Segment

Brief summary

This study is conducted to compare the the investigational device ANTERION with software version 1.5 against the ANTERION with software version 1.2.4 (cleared version)

Interventions

Measurements from the investigational device ANTERION with software version 1.5 are to be compared against measurements from the ANTERION with software version 1.2.4 (cleared version)

Sponsors

Heidelberg Engineering GmbH
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Normal Anterior Segment 1. Age 22 years or older 2. Able and willing to undergo the test procedures, sign informed consent, and follow instructions 3. Able to fixate 4. Eye(s) with normal anterior segment

Exclusion criteria

Normal Anterior Segment 1. Active infection or inflammation in the study eye 2. Insufficient tear film or corneal reflex 3. Physical inability to be properly positioned at the study devices or eye exam equipment 4. Rigid contact lens wear 2 weeks prior to imaging 5. Soft lenses worn within one hour prior to imaging 6. Cataract grade ≥1.5 Inclusion Criteria Abnormal Anterior Segment 1. Age 22 years or older 2. Able and willing to undergo the test procedures, sign informed consent, and follow instructions 3. Able to fixate 4. Eye(s) with abnormal anterior segment (including cataract grade ≥ 1.5)

Design outcomes

Primary

MeasureTime frameDescription
Central Cornea ThicknessThrough study completion, an average of 1 dayReproducibility and repeatability of Central Cornea Thickness of ANTERION and the reference device
Thinnest Point ThicknessThrough study completion, an average of 1 dayReproducibility and repeatability of Thinnest Point Thickness of ANTERION and the reference device
Lens ThicknessThrough study completion, an average of 1 dayReproducibility and repeatability of Lens Thickness of ANTERION and the reference device
Anterior Chamber DepthThrough study completion, an average of 1 dayReproducibility and repeatability of Anterior Chamber Depth of ANTERION and the reference device
Axial LengthThrough study completion, an average of 1 dayReproducibility and repeatability of Axial Length of ANTERION and the reference device

Secondary

MeasureTime frameDescription
Adverse Events RateThrough study completion, an average of 1 dayAdverse events found during the clinical study

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026